- Home
- SRZN vs ASPC Comparison
SRZN vs ASPC Comparison
Compare SRZN & ASPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- ASPC
- Stock Information
- Founded
- SRZN 2015
- ASPC 2024
- Country
- SRZN United States
- ASPC Hong Kong
- Employees
- SRZN N/A
- ASPC N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- ASPC
- Sector
- SRZN Health Care
- ASPC
- Exchange
- SRZN Nasdaq
- ASPC Nasdaq
- Market Cap
- SRZN 82.8M
- ASPC 80.9M
- IPO Year
- SRZN N/A
- ASPC 2024
- Fundamental
- Price
- SRZN $7.10
- ASPC $10.18
- Analyst Decision
- SRZN Strong Buy
- ASPC
- Analyst Count
- SRZN 2
- ASPC 0
- Target Price
- SRZN $38.50
- ASPC N/A
- AVG Volume (30 Days)
- SRZN 11.0K
- ASPC 4.7K
- Earning Date
- SRZN 05-09-2025
- ASPC 01-01-0001
- Dividend Yield
- SRZN N/A
- ASPC N/A
- EPS Growth
- SRZN N/A
- ASPC N/A
- EPS
- SRZN N/A
- ASPC N/A
- Revenue
- SRZN $11,638,000.00
- ASPC N/A
- Revenue This Year
- SRZN N/A
- ASPC N/A
- Revenue Next Year
- SRZN N/A
- ASPC N/A
- P/E Ratio
- SRZN N/A
- ASPC $429.73
- Revenue Growth
- SRZN N/A
- ASPC N/A
- 52 Week Low
- SRZN $6.00
- ASPC $9.95
- 52 Week High
- SRZN $18.17
- ASPC $10.51
- Technical
- Relative Strength Index (RSI)
- SRZN 31.40
- ASPC N/A
- Support Level
- SRZN $9.96
- ASPC N/A
- Resistance Level
- SRZN $11.56
- ASPC N/A
- Average True Range (ATR)
- SRZN 0.96
- ASPC 0.00
- MACD
- SRZN -0.29
- ASPC 0.00
- Stochastic Oscillator
- SRZN 21.20
- ASPC 0.00
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About ASPC A SPAC III Acquisition Corp. Class A Ordinary Shares
A SPAC III Acquisition Corp is a blank check company.